Trials / Completed
CompletedNCT02328807
Focal Prostate Radio-Frequency Ablation
Focal Prostate Radio-Frequency Ablation for the Treatment of Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the safety and efficacy of focal (targeted) Radio-Frequency Ablation (RFA) in men with low or intermediate-risk, clinically localized prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radio-Frequency Ablation (RFA) | RFA is a minimally invasive procedure. It is an image-guided technique that heats and destroys cancer cells. In RFA, imaging techniques such as ultrasound or magnetic resonance imaging (MRI) are used to help guide a needle electrode into a cancerous tumor. High-frequency electrical currents are then passed through the electrode, destroying the cancer cells. |
Timeline
- Start date
- 2014-12-29
- Primary completion
- 2018-05-10
- Completion
- 2021-07-08
- First posted
- 2014-12-31
- Last updated
- 2021-08-06
- Results posted
- 2019-06-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02328807. Inclusion in this directory is not an endorsement.